Search - tctmd.com

Displaying 401 - 420 of 1806

Sort: Relevancy | Date

Presentation TCT 2020

TCT 128: Impact of Time-of-Day of Surgical or Transcatheter Aortic Valve Replacement Procedure on Outcomes: A Propensity-Score Matched Analysis From PARTNER Trials

Presenter: Flavien Vincent

October 14, 2020

News Daily News

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Caitlin E. Cox

October 12, 2020

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

News Daily News

Renal Function Gains Seen in CKD Patients After TAVR

L.A. McKeown

September 15, 2020

News Daily News

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

Caitlin E. Cox

September 14, 2020

News Daily News

US Sees Drop in Hypertension Control

Todd Neale

September 10, 2020

News Daily News

Which TAVR Device Is Best? Review Tackles Optimal Selection

Michael O'Riordan

September 09, 2020

News Conference News ESC 2020

Got Mail? Letter-Based Intervention Doesn’t Boost OAC Initiation for A-fib

Todd Neale

September 03, 2020

News Industry News

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

September 02, 2020

Elective PCI Done Outside the VA System Is Riskier for US Veterans

News Daily News

Elective PCI Done Outside the VA System Riskier for US Veterans

Caitlin E. Cox

August 24, 2020

Podcast TCTMD Talking Points

PARTNER 2A: 5-Year Outcomes

August 19, 2020

News Daily News

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

L.A. McKeown

August 17, 2020

Podcast TCTMD Talking Points

COAPT Cost-effectiveness Analysis Plus Health-Status Outcomes in PARTNER 3

August 05, 2020

News Daily News

More and More, US Cardiologists Joining Larger Practices

Caitlin E. Cox

July 27, 2020

News Industry News

Miracor Medical’s PiCSO® System receives CE Mark

June 23, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

Presentation TVT 2020

SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-risk Patients: A Propensity-Matched Analysis of 5-year Outcomes

Presenter: Susheel K. Kodali

June 21, 2020

News Conference News TVT 2020

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

L.A. McKeown

June 19, 2020

News Daily News

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Michael O'Riordan

May 13, 2020

News Industry News

Corvent Medical, A Coridea Portfolio Company, Closes $4.5m Seed Financing To Commercialize The First Single-Use, Critical Care Ventilator

May 11, 2020

Advertisement

TCT 128: Impact of Time-of-Day of Surgical or Transcatheter Aortic Valve Replacement Procedure on Outcomes: A Propensity-Score Matched Analysis From PARTNER Trials

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Renal Function Gains Seen in CKD Patients After TAVR

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

US Sees Drop in Hypertension Control

Which TAVR Device Is Best? Review Tackles Optimal Selection

Got Mail? Letter-Based Intervention Doesn’t Boost OAC Initiation for A-fib

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

Elective PCI Done Outside the VA System Riskier for US Veterans

PARTNER 2A: 5-Year Outcomes

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

COAPT Cost-effectiveness Analysis Plus Health-Status Outcomes in PARTNER 3

More and More, US Cardiologists Joining Larger Practices

Miracor Medical’s PiCSO® System receives CE Mark

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-risk Patients: A Propensity-Matched Analysis of 5-year Outcomes

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Corvent Medical, A Coridea Portfolio Company, Closes $4.5m Seed Financing To Commercialize The First Single-Use, Critical Care Ventilator

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content